Industry

WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group DMCC, are pleased to announce that Nanocyn® hospital grade … [Read more…]

Transaction to expand CareMax’s comprehensive and coordinated healthcare delivery system designed to improve overall health outcomes for senior value-based care patients Brings CareMax’s high-quality, whole person healthcare to underserved communities with a focus on patients’ social determinants of health to promote health equity Initially adds approximately 170,000 senior value-based care patients across eight states Transaction … [Read more…]

With CGM now part of the Diabetes Canada Clinical Practice Guidelines, Dexcom CGM use is proven to improve glycemic control1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring.3 BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tissue Diagnostic Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global tissue diagnostic market to grow with a CAGR of 7.14% over the forecast period from 2021-2027. The report on the global tissue diagnostic market provides qualitative and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Silicone Foley Catheter Market, By Product Type, Application, By Distribution Channel & By Region – Forecast and Analysis 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global silicone foley catheter market was valued at USD 872.00 Million in 2021, and it is expected to reach a value of USD 1,169.24 Million … [Read more…]

NONNWEILER, Germany–(BUSINESS WIRE)–NGMedical GmbH, a medical device manufacturer exclusively focused on creating innovative technologies for spinal application, announces the launch of its new ART® Fixation System in Europe. The ART® Fixation System was developed with the goal of providing the surgeon with a fixation system to perform dorsal spinal stabilizations simply, quickly and effectively. ART® … [Read more…]

Adds two close-to-market innovative technologies to Healiva’s® growing portfolio of end-to-end care for chronic wounds LUGANO, Switzerland–(BUSINESS WIRE)–#celltherapy—Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® … [Read more…]

PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) has appointed an investment-services provider to purchase 125,000 Ipsen S.A. shares, or about 0.15% of the share capital, over a maximum period of three months. The shares purchased under this agreement will be allocated mainly to cover its employee free share-allocation plan. This program is made pursuant … [Read more…]

Presented today at EULAR 2022, data from a new post-hoc analysis show a statistically significant difference in clinical outcomes with subcutaneous (SC) infliximab compared to intravenous (IV) infliximab at week 30, using conservative missing imputation methods Data also show that differences in efficacy outcomes between SC and IV infliximab groups reduced at week 54, after … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, announces the grant of stock options pursuant to its stock option plan to certain directors of the Company to … [Read more…]